Genomics in Cancer Care Market: Explosive Growth a..

创建了一篇新文章

3 d

Genomics in Cancer Care Market: Explosive Growth as Liquid Biopsy, Minimal Residual Disease Testing, and Non-Invasive Genomic Monitoring Redefine Cancer Management | #healthcare

Genomics in Cancer Care Market: Explosive Growth as Liquid Biopsy, Minimal Residual Disease Testing, and Non-Invasive Ge

The market was valued at roughly USD 46.6–53.7 billion in 2024–2025 and is projected to reach about USD 219–220 billion by 2035

喜欢

3 d

Genomics in Cancer Care Market: Explosive Growth as Liquid Biopsy, Minimal Residual Disease Testing, and Non-Invasive Ge

语